Funding

1nhaler

United Kingdom · Healthtech

1nhaler develops a compact, single-dose dry powder inhaler made predominantly from cardboard.

Visit 1nhaler.comFunding history

Drug delivery device

The Edinburgh company is developing a flat, credit-card-shaped device that opens into a three-dimensional inhaler. A patented membrane system delivers a single dose of dry powder without a propellant.

Lead product

Its lead product combines the device with salbutamol, an established asthma medicine. Development work includes clinical trial manufacturing and a clinical study to support a planned regulatory filing in late 2027.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Follow-on funding£2.2MArchangels — LeadBBB Investments — ParticipantScottish Enterprise — Participant

Investors

ArchangelsLed Follow-on fundingBBB InvestmentsJoined Follow-on fundingScottish EnterpriseJoined Follow-on funding

Coverage

Nov 3, 20261nhaler · Follow-on funding

Similar companies

NanochapDevelops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception.CN¥500M · Series C+
Atomic SoftwareAtomic Software develops industry-specific business software, including the medicalforce platform for clinic operations.¥600M · Series C
BionicMBionicM develops powered prosthetic legs that use robotics to assist movement for people with lower-limb amputations.¥710M · Series B first close
Sourcesscottish-enterprise-mediacentre.com ↗1nhaler.com ↗